ASEAN Morning Bytes
Asian markets to get a boost from positive developments on the vaccine front
EM Space: Optimism over second vaccine development to bolster sentiment
- General Asia: Asian markets are likely to get a lift from positive developments on the vaccine front with a second candidate vaccine reporting encouraging numbers. Hopes for an official approval for emergency use are high, helping lift sentiment although Covid-19 new infections continue to spike across the globe. US President Trump insists he won the election and shows little sign of conceding to President-Elect Biden. Economic data on Tuesday features Singapore non-oil domestic exports and US retail sales. Investors will likely keep an eye on developments on the pandemic, monitoring new cases and possible government actions while also watching vaccine development for more direction.
- Thailand: The year-on-year GDP contraction almost halved to -6.4% in 3Q from -12.1% in 2Q. This was better than our -8.2% forecast for the quarter and pushes our full-year forecast up to -6.2% from -6.7%, aligning with the official growth view of -6.0%. However, risks remain tilted to the downside as the second wave of the pandemic threatens the recovery of the economy which is heavily reliant on tourism and exports (read more here).
- Singapore: October Non-oil domestic exports (NODX) surprised on the downside with a -5.3% MoM SA and -3.1% YoY contraction (ING forecasts +4.9% MoM and +6.5% YoY). This was the second straight month-on-month fall, following -11.4% MoM in September, and may hint at possible cracks developing in Singapore’s export-led recovery as the second-wave of global Covid-19 outbreak is causing havoc in its main trading partners. Reinforcing this was a 28% MoM plunge in shipments to Europe and a 19% plunge in those to Malaysia, though exports to the US bucked the trend with 16% MoM bounce. By product type, electronics were a source of negative headline NODX growth in October, while pharmaceuticals outperformed with a 73% MoM surge. The Monetary Authority of Singapore’s neutral policy stance, targeting zero appreciation of the trade-weighted SGD exchange rate (S$-NEER), may serve to support Singapore’s external competitiveness going forward, but the resurgent global pandemic could hold back the recovery.
- Philippines: Bangko Sentral ng Pilipinas (BSP) reported that overseas Filipino (OF) remittances grew 9.3% for September, much better than market analysts had expected (4.3% drop for the month). This brings the year-to-date total to $21.9 bn, down 1.4% with the BSP expecting remittances to contract by less than 2% for the year. The surprise bounce in remittances may be traced to some economies opening up after lockdowns in 2Q and as Filipinos sent home life savings ahead of repatriation. We expect weakness in remittances for 4Q with lockdowns reinstated around the globe and with the stock of Filipinos abroad depleted after 300,000 Filipinos returned home after job losses in host countries.
- Indonesia: October trade numbers showed both exports and imports contracting although the steeper drop in imports caused the trade surplus to swell to multi-year highs. The trade surplus hit $3.6 bn, the highest since 2011, which should be supportive of IDR in the near term although successive months of weaker imports could take its toll on productive capacity in the coming months. We expect exports and imports to remain soft amidst the pandemic but the recent signing of the sweeping trade pact between Asia Pacific countries could signal a rebound next year.
What to look out for: US retail sales and Covid-19 developments
- Singapore non-oil domestic exports (17 November)
- US retail sales and industrial production (17 November)
- Bank of Thailand policy meeting (18 November)
- US building permits and housing starts (18 November)
- Bank Indonesia policy meeting (19 November)
- Bangko Sentral ng Pilipinas policy meeting (19 November)
- US initial jobless claims and existing home sales (19 November)
- Malaysia GIR (20 November)
- Thailand GIR (20 November)
- Fed’s Kaplan, Bostic and Barkin give speeches (20 November)
Download
Download article
17 November 2020
Good MornING Asia - 17 November 2020 This bundle contains {bundle_entries}{/bundle_entries} articles"THINK Outside" is a collection of specially commissioned content from third-party sources, such as economic think-tanks and academic institutions, that ING deems reliable and from non-research departments within ING. ING Bank N.V. ("ING") uses these sources to expand the range of opinions you can find on the THINK website. Some of these sources are not the property of or managed by ING, and therefore ING cannot always guarantee the correctness, completeness, actuality and quality of such sources, nor the availability at any given time of the data and information provided, and ING cannot accept any liability in this respect, insofar as this is permissible pursuant to the applicable laws and regulations.
This publication does not necessarily reflect the ING house view. This publication has been prepared solely for information purposes without regard to any particular user's investment objectives, financial situation, or means. The information in the publication is not an investment recommendation and it is not investment, legal or tax advice or an offer or solicitation to purchase or sell any financial instrument. Reasonable care has been taken to ensure that this publication is not untrue or misleading when published, but ING does not represent that it is accurate or complete. ING does not accept any liability for any direct, indirect or consequential loss arising from any use of this publication. Unless otherwise stated, any views, forecasts, or estimates are solely those of the author(s), as of the date of the publication and are subject to change without notice.
The distribution of this publication may be restricted by law or regulation in different jurisdictions and persons into whose possession this publication comes should inform themselves about, and observe, such restrictions.
Copyright and database rights protection exists in this report and it may not be reproduced, distributed or published by any person for any purpose without the prior express consent of ING. All rights are reserved.
ING Bank N.V. is authorised by the Dutch Central Bank and supervised by the European Central Bank (ECB), the Dutch Central Bank (DNB) and the Dutch Authority for the Financial Markets (AFM). ING Bank N.V. is incorporated in the Netherlands (Trade Register no. 33031431 Amsterdam).